Precision medicine represents a significant shift in healthcare, moving from a generalized approach to a more personalized strategy that considers a person's genetic makeup, environmental and lifestyle. Within this field, cell and gene therapies have emerged as promising tools for improving patient care—with cell therapy involving the transferring of live cells into a patient and gene therapy modifying a person’s genetic code to treat or cure specific health conditions.
Bioanalysis is crucial for cell and gene therapy development in both the preclinical and clinical phases of drug development. However, given the nature of cell and gene therapies, traditional bioanalytical methodologies and instrumentation originally designed for small and large molecule treatments do not suffice. Specific molecular bioanalytical methodologies and instrumentation for biodistribution, vector shedding, vector copy number, and cellular kinetics are required to advance cell and gene therapies along the drug development continuum.
Novel Therapies
years Experience
Methods Annually
Global Sites
With over 20 years of molecular bioanalytical experience and industry thought leadership insights, we can help you advance even your most challenging projects when it matters most. Located across four global sites in the U.S., U.K.and Asia, we are ready to partner with you to help you achieve your next milestone.
Your innovative therapies deserve cutting-edge support. That's why we've recently invested in lab expansions that have quadrupled our capacity in molecular bioanalytical services, meeting the growing complexities of the biopharmaceutical landscape.
Our recently expanded footprint helps reduce lead times for your advanced cell and gene therapies, empowering you with critical speed—without compromising high quality and consistent results. Backed by our 20+ years of molecular bioanalytical experience, our global network is better equipped to expedite your breakthroughs, whether you're focused on oncology, rare diseases or other therapeutic areas. Our increased scale is your advantage, helping you bring life-saving treatments to patients sooner.
For more information, read our recent press release.
Labcorp’s global leadership team maintains consistent quality through aligned technology platforms and standardized operating procedures across all locations. Benefit from our deeply scientific and technical exchange network, providing you with cutting-edge expertise and innovative solutions to drive your therapies forward efficiently and effectively.
For more molecular bioanalysis scientific news and to meet our scientific staff, please visit: https://www.labcorp.com/science/bioanalytical-insights#scientists
